UNOPS hosts the Stop Tuberculosis Partnership Secretariat
(STBP) as of 1 January 2015, in Geneva, Switzerland. The vision of the Stop TB
Partnership is to realize the goal of elimination of Tuberculosis (TB) as a
public health problem and, ultimately, to obtain a world free of TB by ensuring
that every TB patient has access to effective diagnosis, treatment and cure;
stopping transmission of TB; reducing the inequitable social and economic toll
of TB; and developing and implementing new preventive, diagnostic and
therapeutic tools and strategies. The Stop Partnership is uniquely positioned
to support the development and further implementation by partners of the
current and future Global Plan, acting as a coordinator and catalyst for the
range of partners engaged in the fight against TB.
As a key initiative of the Stop TB Partnership, the goal
of the Global Drug Facility (GDF) is to facilitate worldwide, equitable access
to TB medicines and diagnostics across both public and private sectors. This
goal is achieved through management and coordination of market activities for
the full portfolio of TB medicines and diagnostics, strategic procurement and
innovative logistics solutions, technical assistance and capacity building for
TB programmes in better pharmaceutical management practices, and accelerated
uptake of new TB medicines, regimens, and diagnostics using the GDF Launch Pad.
In an assigned region/portfolio of countries, under the
guidance of the GDF Demand, Technical Assistance, and Capacity Building (DTC)
Team leader, the GDF Regional Technical Advisor (RTA) promotes the StopTB
Partnership and the GDF policies and strategies, and serves as a regional technical leader and procurement and supply
management (PSM) expert to advise and coordinate countries, donors and
stakeholders, identify regional and country supply systems improvement needs
and opportunities, and actively manage technical assistance and capacity
strengthening to ensure continuous access to anti-TB medicines and laboratory
products, and an expedited uptake of new treatment and diagnostic tools as part
of the GDF Launchpad approach. This goal is achieved through promotion of best
PSM practices, new TB tools, and strengthening forecasting, quantification,
supply planning, transition-to-new-tools planning and monitoring, and
implementation of early warning systems (EWS) to avoid treatment interruptions
or waste of TB products.
RTA may be involved, as required, in broader spectrum of
activities related to pharmaceutical systems strengthening, supply chain
management, management information systems, pharmaceutical services, and
providing technical leadership to countries, donors and technical agencies in
the field.
The RTA works closely with the GDF Country Supply
Officers, other GDF teams, and contributes to the implementation of the
StopTB/GDF strategy. The RTAs will be
based in key regions.
The RTA is the primary liaison between the GDF and
national TB programs, donor-funded regional and field TB programs, such as by
USAID and the Global Fund (GF), the GF Principal Recipients, Government
counterparts, stakeholders, and partners involved in pharmaceutical management
activities and/or implementing related programs in the countries and region.
The RTA is responsible for the deployment of the GDF tools and frameworks and
their adequate customization and ownership at the country level. RTA works with
international and national stakeholders to ensure that technical assistance and
capacity building activities to countries in the portfolio are adequately
effective and that deliverables are meeting quality standards. RTA supports measurement and documentation of
portfolio results. The RTA also
contributes and supports the GDF capacity building and knowledge exchange
plans.
The position requires
ability to travel outside the base country at least 40% of time.